Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joyce J. B. C. van Beers"'
Publikováno v:
Antibodies, Vol 13, Iss 3, p 73 (2024)
Background: Therapeutic drug monitoring of biological Tumor Necrosis Factor (TNF)-alpha inhibitors is of critical importance. In this study, the performance of practically advantageous chemiluminescent immunoassays of Theradiag, assessing Infliximab
Externí odkaz:
https://doaj.org/article/00f3ef3f8a04475dbef25769384a77b9
Autor:
Matthias H. Busch, Joop P. Aendekerk, Joyce J. B. C. van Beers, Pieter van Paassen, Jan G. M. C. Damoiseaux
Publikováno v:
Autoimmunity, Vol 54, Iss 1, Pp 45-50 (2021)
The use of high-quality antigen-specific immunoassays for detecting anti-neutrophil cytoplasmic antibodies (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies is recommended in patients with suspected ANCA vasculitis and/or anti-GBM dis
Externí odkaz:
https://doaj.org/article/64a38648717f4d7f99a3e7310d2a5256
Publikováno v:
International Journal of Laboratory Hematology, 45, e93-e94. Wiley
Publikováno v:
Journal of Applied Laboratory Medicine. 7(1):259-267
Background Primary biliary cholangitis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are autoimmune liver diseases associated with distinct autoantibodies. Diagnosis is based upon clinical, serological, and histopathology
Publikováno v:
Therapeutic Antibodies ISBN: 9781071614495
Therapeutic Antibodies, 2313, 45-55
Therapeutic Antibodies, 2313, 45-55
B-cell depleting therapy is increasingly used in the treatment of many distinct autoimmune diseases. This not only involves remission induction therapy, but also maintenance therapy. In this respect, it is of importance to monitor composition of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd4f40ceb9227c1e2c218ea3df56515
https://doi.org/10.1007/978-1-0716-1450-1_3
https://doi.org/10.1007/978-1-0716-1450-1_3
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2313
Over the years, a wide variety of therapeutic antibodies has been successfully introduced in the autoimmunology clinic and many more are on the edge to follow. Many of these treatments address either a pathogenic circulating molecule or a cell-bound
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2313
B-cell depleting therapy is increasingly used in the treatment of many distinct autoimmune diseases. This not only involves remission induction therapy, but also maintenance therapy. In this respect, it is of importance to monitor composition of the
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 116, p 116 (2021)
Biomolecules, Vol 11, Iss 116, p 116 (2021)
Over the years, a wide variety of therapeutic antibodies has been successfully introduced in the auto-immunology clinic, and many more are on the way. Many of these treatments address either a pathogenic circulating molecule or a cell-bound molecule.
Autor:
Pieter van Paassen, Joop P. Aendekerk, Matthias Busch, Jan Damoiseaux, Joyce J. B. C. van Beers
Publikováno v:
Autoimmunity, 54(1), 45-50. Informa Healthcare
The use of high-quality antigen-specific immunoassays for detecting anti-neutrophil cytoplasmic antibodies (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies is recommended in patients with suspected ANCA vasculitis and/or anti-GBM dis
Autoantibodies are widely incorporated in the disease criteria of the systemic autoimmune rheumatic diseases. Unfortunately, standardization of laboratory assays for the detection of autoantibodies is lacking. Therefore, critical appraisal of the tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a128fe51bf99c58bb60b6805fd7862d
https://doi.org/10.1016/b978-0-12-814307-0.00010-4
https://doi.org/10.1016/b978-0-12-814307-0.00010-4